PERM ALS MARKER DES ENDOMETRIELLEN KREBS

European patent · EP3452829 · In force

Register entry

Publication number
EP3452829
Application number
EP17713973
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 30, 2017
Published
Mar 13, 2019
Granted
Jan 24, 2024
Protection ends at the latest
Mar 29, 2037
Next annual fee due
Mar 31, 2027
IPC classes
G01N 33/574 (2006.01)
Priority
EP 16168328 04.05.2016
PCT application
PCT/EP2017/057635 30.03.2017
PCT publication
WO2017/190896 09.11.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Dec 4, 2024

    Change

    Published in Swissreg on 04.12.2024

  4. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  5. Mar 27, 2024

    Agent entered

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 27.03.2024

  6. Jan 24, 2024

    Granted

    Published in Swissreg on 24.01.2024

Parties

Holder

Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca

Passeig Vall d'Hebrón, 119-129, 08035 Barcelona, ES

Agent

Bovard AG

BOVARD AG

Optingenstrasse 16, 3013 Bern

Inventor

COLÁS ORTEGA, Eva

08020 Barcelona, ES

MARTINEZ GARCÍA, Elena

09002 Burgos, ES

DOMON, Bruno

2534 Orvin

LESUR, Antoine

8010 Strassen, LU

GIL MORENO, Antonio

08172 Sant Cugat del Vallès, ES

REVENTÓS PUIGJANER, Jaume

08348 Cabrils, ES

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.